Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 (COVID-19)

Clinical Trial ID NCT04474483

Rank	Title	Journal	Year	PubWeight™‹?›
1	Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.	Lancet	2020	18.32
2	COVID-19: Melatonin as a potential adjuvant treatment.	Life Sci	2020	3.30
3	Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.	J Virol	2005	1.76
4	Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells.	Blood	2005	1.52
5	The Safety of Melatonin in Humans.	Clin Drug Investig	2016	0.86
6	Melatonin reduces acute lung injury in endotoxemic rats.	Chin Med J (Engl)	2009	0.84
7	Effects of melatonin in an experimental model of ventilator-induced lung injury.	Am J Physiol Lung Cell Mol Physiol	2008	0.82
8	Melatonin reduces acute lung inflammation, edema, and hemorrhage in heatstroke rats.	Acta Pharmacol Sin	2012	0.80
9	Melatonin improves inflammatory cytokine profiles in lung inflammation associated with sleep deprivation.	Mol Med Rep	2012	0.79
10	Melatonin reduces airway inflammation in ovalbumin-induced asthma.	Immunobiology	2014	0.78
11	Oral melatonin attenuates lung inflammation and airway hyperreactivity induced by inhalation of aerosolized pancreatic fluid in rats.	J Pineal Res	2010	0.78
12	Melatonin Attenuates Upregulation of Duox1 and Duox2 and Protects against Lung Injury following Chest Irradiation in Rats.	Cell J	2019	0.75